<PAGE> 1
- ------------------ -----------------------------
FORM 3/A OMB APPROVAL
- ------------------ -----------------------------
OMB NUMBER 3235-0104
EXPIRES: SEPTEMBER 30, 1998
ESTIMATED AVERAGE BURDEN
HOURS PER RESPONSE.....0.5
------------------------------
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section
17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the
Investment Company Act of 1940
(Print or Type Responses)
- --------------------------------------------------------------------------------
1. Name and Address of Reporting Person
Weisbach, Ph.D. Jerry
- --------------------------------------------------------------------------------
(Last) (First) (Middle)
c/o InKine Pharmaceutical Company, Inc.
Sentry Park East, 1720 Walton Road
- --------------------------------------------------------------------------------
(Street)
Blue Bell, PA 19422
- --------------------------------------------------------------------------------
(City) (State) (Zip)
- --------------------------------------------------------------------------------
2. Date of Event Requiring Statement (Month/Day/Year) 11/6/97
- --------------------------------------------------------------------------------
3. IRS or Social Security Number of Reporting Person (Voluntary)
- --------------------------------------------------------------------------------
4. Issuer Name and Ticker or Trading Symbol
InKine Pharmaceutical Company, Inc. (INKP)
- --------------------------------------------------------------------------------
5. Relationship of Reporting Person to Issuer
(Check all applicable)
[ x ] Director [ ] 10% Owner
[ ] Officer (give title below) [ ] Other (specify below)
- --------------------------------------------------------------------------------
6. If Amendment, Date of Original (Month/Day/Year)
11/17/97
- --------------------------------------------------------------------------------
7. Individual or Joint/Group Filing (Check Applicable Line)
[ X ] Form filed by One Reporting Person
[ ] Form filed by More than One Reporting Person
- --------------------------------------------------------------------------------
TABLE I - NON-DERIVATIVE SECURITIES BENEFICIALLY OWNED
<TABLE>
<CAPTION>
- --------------------------------------------------------------------------------------------------------------------------------
1. Title of Security 2. Amount of Securities 3. Ownership 4. Nature of Indirect Beneficial Ownership
(Instr. 4) Beneficially Owned Form: Direct (Instr. 5)
(Instr. 4) (D) or Indirect
(I) (Instr. 5)
- --------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
None
- --------------------------------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------------------------------
- --------------------------------------------------------------------------------------------------------------------------------
</TABLE>
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly. *If the form is filed by more than one reporting
person, see Instruction 5(b)(v).
(Over)
SEC 1473 (7-96)
<PAGE> 2
FORM 3 (continued)
TABLE II - DERIVATIVE SECURITIES BENEFICIALLY OWNED (E.G.,
PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES)
<TABLE>
<CAPTION>
- -----------------------------------------------------------------------------------------------------------------------------------
1. Title of Derivative 2. Date Exercisable 3. Title and Amount of Securities 4. Conver- 5. Owner- 6.Nature of Indirect
Security (Instr. 4) and Expiration Underlying Derivative Security sion or ship Beneficial Ownership
Date (Instr. 4) Exercise Form of (Instr. 5)
(Month/Day/Year) Price of Deriv-
Deri- ative
------------------------------------------------------- vative Security:
Amount Security Direct
Date Exer- Expira- or (D) or
cisable tion Title Number Indirect
Date of (I)
Shares (Instr.5)
- -----------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C>
Stock Option
(Right to Buy) * 11/6/07 Common Stock 100,000 $1.00 D
- -----------------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------------
</TABLE>
Explanation of Responses:
* Option became exerciseable as to 33,333 shares on November 6, 1997. It
will become exerciseable with respect to the balance of the shares in annual
increments of 16,666.75 shares commencing on November 6, 1998.
** Intentional misstatements or omissions of facts constitute Federal
Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If
space provided is insufficient, See Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB Number.
/s/Jerry Weisbach, Ph.D. 2/9/98
- --------------------------------------- --------------
** Signature of Reporting Person Date
Jerry Weisbach, Ph.D.
Page 2
SEC 1473 (7-96)
